Business brief
Industrial Tension, Biotech Bets, and Studio Antitrust Clashes
Labor disputes, billion-dollar pharma bets, and state antitrust clashes shape the US corporate outlook.
Business
State antitrust enforcement is hardening against studio consolidation — keeping Paramount's $111 billion merger locked in court.
BackgroundParamount's mega-merger with Warner Bros. Discovery would combine major Hollywood film studios, broadcast networks, and streaming services. State antitrust regulators argue consolidation limits industry competition and harms consumer pricing.
- Attorney General Bonta accused Paramount of leaking confidential settlement parameters to media outlets, destroying trust between negotiating parties.
- California leads a coalition of 12 states seeking to block the $111 billion entertainment combination in federal district court.
- State regulators contend combining the major studios will reduce media employment and concentrate television streaming market power.
Business
Pharma giants are placing billion-dollar bets on muscle-sparing obesity therapies — aiming to address key clinical drawbacks of first-generation GLP-1 drugs.
BackgroundGlobal pharmaceutical firms are racing to secure next-generation metabolic drugs that preserve lean muscle mass during weight loss. Existing GLP-1 therapies frequently induce muscle loss alongside fat reduction.
- Genentech paid $190 million upfront and committed up to $2.12 billion in development and commercial milestone payments to secure global commercialization rights.
- HM17321 is an investigational candidate designed to selectively trim fat mass while maintaining skeletal muscle function during weight loss.
- The deal bolsters Roche's late-stage metabolic portfolio as competition intensifies against market incumbents Eli Lilly and Novo Nordisk.
Business
Agricultural workers are prioritizing job security over short-term wage bonuses — refusing to extend contracts while manufacturing layoffs continue.
BackgroundDeere has faced weakening farm equipment demand across North America as agricultural commodity prices softened. UAW union members previously went on strike against Deere in 2021 before securing a six-year master agreement that expires in fall 2027.
- Deere offered 4% annual wage increases and cash bonuses to extend the master labor agreement through 2029, seeking labor cost predictability.
- UAW leadership criticized management for bypassing formal collective bargaining while 1,600 production workers remain laid off across several Midwestern manufacturing plants.
- The rejection keeps current labor terms expiring in fall 2027, leaving labor relations uncertain while equipment demand continues to decline.
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
